Key Insights

Highlights

Treatment Research

3 treatments under study, led by Additional Sample Collections

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Suspended1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04306939Suspended

Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study

Showing all 1 trials

Research Network

Common Treatments

  • Additional Sample Collections1
  • Questionnaires1
  • Venipuncture1

Active Sponsors

  • University of Pittsburgh1

Top Investigators

Related Conditions

  • Hepatitis1
  • Chronic Kidney Diseases1
  • Bile Acid Synthesis Defect1
  • Inflammatory Bowel Diseases1
  • Irritable Bowel Syndrome1

Activity Timeline